{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:58:32Z","timestamp":1767963512690,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ejmech.2014.10.007","type":"journal-article","created":{"date-parts":[[2014,10,5]],"date-time":"2014-10-05T20:09:11Z","timestamp":1412539751000},"page":"611-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Scaffold hopping approach on the route to selective tankyrase inhibitors"],"prefix":"10.1016","volume":"87","author":[{"given":"Paride","family":"Liscio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Carotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Asciutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maira M.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Valloscuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Ziff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil R.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Macchiarulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart A.","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pellicciari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emidio","family":"Camaioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.10.007_bib1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/embor.2008.191","article-title":"The expanding field of poly(ADP-ribosyl)ation reactions. \u2018Protein modifications: beyond the usual suspects\u2019 review series","volume":"9","author":"Hakm\u00e9","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejmech.2014.10.007_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tibs.2009.12.003","article-title":"Toward a unified nomenclature for mammalian ADP-ribosyltransferases","volume":"35","author":"Hottinger","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2014.10.007_bib3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nrd3868","article-title":"Tankyrase-targeted therapeutics: expanding opportunities in the PARP family","volume":"11","author":"Riffell","year":"2012","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.ejmech.2014.10.007_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1128\/JVI.05897-11","article-title":"Herpes simplex virus requires poly(ADP-ribose) polymerase activity for efficient replication and induces extracellular signal-related kinase-dependent phosphorylation and ICP0-dependent nuclear localization of tankyrase 1","volume":"86","author":"Li","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2014.10.007_bib5","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1128\/JVI.79.8.4640-4650.2005","article-title":"Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1","volume":"79","author":"Deng","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2014.10.007_bib6","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1074\/jbc.M111.322123","article-title":"Axin pathway activity regulates in\u00a0vivo pY654-beta-catenin accumulation and pulmonary fibrosis","volume":"287","author":"Ulsamer","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib7","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.2337\/db08-1781","article-title":"Hypermetabolism, hyperphagia, and reduced adiposity in tankyrase-deficient mice","volume":"58","author":"Yeh","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2014.10.007_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nbt.2121","article-title":"Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors","volume":"30","author":"Wahlberg","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2014.10.007_bib9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature08356","article-title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling","volume":"461","author":"Huang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2014.10.007_bib10","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1021\/jm400211f","article-title":"Fragment-based ligand design of novel potent inhibitors of tankyrases","volume":"56","author":"Larsson","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib11","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/cmdc.201300337","article-title":"para-Substituted 2-phenyl-3,4-dihydroquinazolin-4-ones as potent and selective tankyrase inhibitors","volume":"8","author":"Haikarainen","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2014.10.007_bib12","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1021\/jm400826j","article-title":"Structure\u2212efficiency relationship of [1,2,4]triazol-3-ylamines as novel nicotinamide isosteres that inhibit tankyrases","volume":"56","author":"Shultz","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib13","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1021\/jm401356t","article-title":"Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors","volume":"57","author":"Liscio","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nchembio.137","article-title":"Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer","volume":"5","author":"Chen","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2014.10.007_bib15","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1021\/jm201510p","article-title":"Structural basis of selective inhibition of human tankyrases","volume":"55","author":"Narwal","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib16","doi-asserted-by":"crossref","first-page":"e33740","DOI":"10.1371\/journal.pone.0033740","article-title":"Novel binding mode of a potent and selective tankyrase inhibitor","volume":"7","author":"Gunaydin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2014.10.007_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1158\/0008-5472.CAN-10-1282","article-title":"Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth","volume":"71","author":"Waaler","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2014.10.007_bib18","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1021\/jm4000566","article-title":"Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1\/2 inhibitor","volume":"56","author":"Voronkov","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib19","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1021\/jm4000038","article-title":"Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors","volume":"56","author":"Bregman","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib20","doi-asserted-by":"crossref","first-page":"10003","DOI":"10.1021\/jm401317z","article-title":"Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors","volume":"56","author":"Hua","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib21","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.2174\/15680266113136660209","article-title":"From polypharmacology to target specificity: the case of PARP inhibitors","volume":"13","author":"Liscio","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1107\/S1744309111051219","article-title":"Structure of human tankyrase 1 in complex with small-molecule inhibitors PJ34 and XAV939","volume":"68","author":"Kirby","year":"2012","journal-title":"Acta Crystallogr. Sect. F."},{"key":"10.1016\/j.ejmech.2014.10.007_bib23","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1021\/jm100249w","article-title":"Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor","volume":"53","author":"Karlberg","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib24","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/jhet.5570230563","article-title":"The synthesis of dimethoxy[l]benzothieno[2,3-c]quinolines","volume":"23","author":"Pakray","year":"1986","journal-title":"J.\u00a0Het. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib25","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/jhet.5570240606","article-title":"The synthesis of [l]benzothieno[2,3-c]quinolines, [l]benzothieno[2,3-c][1,2,4]triazolo[4,3-a]quinoline, and [l]benzothieno[2,3-c]tetrazolo[1,5-a]quinoline","volume":"24","author":"McKenney","year":"1987","journal-title":"J.\u00a0Het. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/jhet.5570240435","article-title":"The synthesis of monomethoxy[l]benzothieno[2,3-c]quinolines","volume":"24","author":"Castle","year":"1987","journal-title":"J.\u00a0Het. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib27","first-page":"439","article-title":"Thieno[2,3-c]chinoline \u2013 synthese und biologische pr\u00fcfung","volume":"59","author":"Gorlitzer","year":"2004","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejmech.2014.10.007_bib28","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1080\/00397919008051593","article-title":"Synthesis of 2-hydroxyquinolines from 2-amino-benzophenones and N,N-dimethylacetamide","volume":"20","author":"Chorbadjiev","year":"1990","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2014.10.007_bib29","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.tet.2013.02.069","article-title":"Efficient synthesis of novel thieno[3,2-b]-, [2,3-c]- and [3,2-c]pyridones by Sonogashira coupling of bromothiophenes with terminal alkynes and subsequent intramolecular C-N bond-forming reaction","volume":"69","author":"Iaroshenko","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.10.007_bib30","first-page":"1428","article-title":"Synthesis of a novel series of thieno[3,2-d]pyrimidin-4-(3H)-ones","volume":"9","author":"Abdillahi","year":"2010","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2014.10.007_bib31","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1021\/jo00954a008","article-title":"Synthesis of [l]benzothieno[3,2-d]pyrimidine derivatives","volume":"38","author":"Beck","year":"1973","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jorganchem.2010.08.033","article-title":"Palladium(II) 3-iminophosphine (3IP) complexes: active precatalysts for the intermolecular hydroamination of 1,2-dienes (allenes) and 1,3-dienes with aliphatic amines under mild conditions","volume":"696","author":"Kuchenbeiser","year":"2011","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib33","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1021\/jm8001263","article-title":"4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1","volume":"51","author":"Menear","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib34","first-page":"18","article-title":"Evaluation and structural basis for the inhibition of tankyrases by PARP inhibitors","volume":"20","author":"Haikarainen","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2014.10.007_bib35","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1021\/jm300505h","article-title":"Novel substituted benzothiophene and thienothiophene carboxanilides and quinolones: synthesis, photochemical synthesis, DNA-binding properties, antitumor evaluation and 3D-derived QSAR analysis","volume":"55","author":"Aleksi\u0107","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tetlet.2010.11.076","article-title":"A\u00a0new facile synthesis of methyl 3-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxylate","volume":"52","author":"Tenora","year":"2011","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2014.10.007_bib37","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.bmc.2012.04.021","article-title":"Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of farnesoid X receptor (FXR) agonists","volume":"20","author":"Marinozzi","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.007_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","article-title":"PHASE: a novel approach to pharmacophore modeling and 3D database searching","volume":"67","author":"Dixon","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2014.10.007_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/ci00017a013","article-title":"Computation and management of chemical properties in CACTVS: an extensible networked approach toward modularity and compatibility","volume":"34","author":"Ihlenfeldt","year":"1994","journal-title":"J.\u00a0Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2014.10.007_bib40","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/ci000150t","article-title":"Comparison of the NCI open database with seven large chemical structural databases","volume":"41","author":"Voigt","year":"2001","journal-title":"J.\u00a0Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2014.10.007_bib41","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2002"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414009337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414009337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T14:01:14Z","timestamp":1584021674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414009337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":41,"alternative-id":["S0223523414009337"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.10.007","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scaffold hopping approach on the route to selective tankyrase inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}